Latest From the
world of Reformulary

Reformulary Group launches drug coverage exception process

Cannabis Standard Index brings much-needed clarity to medical cannabis

Reformulary Group announces preferred pharmacy partnership with Rexall

Reformulary Group launches Quality of Life tool for prescription drugs and cannabis

Reformulary Group joins BlackNorth Initiative to combat anti-black racism in Canadian business

Reformulary Group Announces Partnership with VIVO Cannabis

Reformulary Group launches COVID-19 DEW Report

New study underscores importance of medical cannabis rating system

Reformulary 2019 Year in Review

Cannabis Standard Insights, Issue #2 published by Reformulary Group

CIX Canadian Innovation Exchange announced Reformulary Group as a CIX TOP 20 Early innovative Canad...

Letter to the editor: Pharmacare – not all Canadians, not all drugs